This is an odd note to write. Like most publications, we had a topic before the virus happened. Rapidly responding to current events, we added a pandemic piece and devoted two podcasts to the topic. Catch those online by searching for “Carlat” on your podcast store.
Read More
The COVID19 pandemic has transformed child and adolescent psychiatry overnight. How do we manage telehealth? What about medications? What are the new rules and boundaries and what can we expect from our patients? Most important, how do we support parents to help their children?
Read More
While air pollution has lifted a bit with the global pause for the pandemic, this merely underlines the problems created by particulate matter, injuring children and causing both psychical and direct mental health sequelae. This article reviews the impact of air pollution on children and gives practical suggestions on mitigating those effects.
Read More
How do we understand the range of psychotic disorders in children and adolescents and how does this understand impact treatment in a more differentiated way? This interview helps clinicians to sort through what kinds of psychotic processes are at play and how to approach them in a more nuanced manner, while giving practical and realistic advice for patient management.
Read More
Psychotic disorders in children and adolescents include a range of neuropsychiatric problems related to the multitude of underlying neurophysiological differences and the problems created by these differences. Chief among these are cognitive impacts. This interview helps outline and give guidance for managing these cognitive problems related to both psychosis and to the medication treatments that themselves can add to these problems.
Read More
Can parents impact teen sleep in a helpful manner? Teens are notorious for staying up late and having trouble getting up in the morning. We are often asked to opine on this problem. This research review looks at the effect of such intervention, including the consideration of the difference between a ‘significant finding’ and one that is clinically meaningful.
Read More
Dr. Joshua Feder studied mathematics and medicine at Boston University, Psychiatry at Naval Regional Medical Center San Diego, serving the first Gulf War in child and adolescent psychiatry fellowship at Tripler Army Medical Center in Honolulu, and eventually became Chief of Child Psychiatry at the National Naval Medical Center in Bethesda, MD. Dr. Feder now practices in Solana Beach, California, and serves as Executive Medical Director at Positive Development, providing relationship-based support for families, with research at UCSD, SDSU, Fielding Graduate University, An Najah National University, Quicksilver Software, Autism Is inclusion program, and Programmatic Lead for the International Networking Group on Peace Building with Young Children, with projects in the US, Northern Ireland, and the Middle East. Dr. Feder co-authored the first American Academy of Child & Adolescent Psychiatry Practice Parameter on Autism and serves as Co-Chair of the Disaster & Trauma Committee at AACAP. Dr Feder was founding policy chair for the California Association for Infant Mental Health and advocates worldwide on access to care, climate policy, and peacebuilding. His recent books include Child Medication Fact Book for Psychiatric Practice, Second Edition (2023) and Prescribing Psychotropics (2021).
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
